Laura E. Niklason, President, CEO and Director at Humacyte, Inc. (HUMA), sold 978,296 shares at $7.02 ($7.0M) on 2024-06-11, disclosed to the SEC on 2024-06-13.
Open-market sale of $7.0M HUMA by President, CEO and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.02 | 76,630 | $538K | 7.6% |
| 2 | $7.02 | 76,630 | $538K | 7.6% |
| 3 | $7.09 | 282,000 | $2.0M | 28.4% |
| 4 | $7.30 | 271,518 | $2.0M | 28.2% |
| 5 | $7.30 | 271,518 | $2.0M | 28.2% |
| Total | $7.20 avg | 978,296 |
| $7.0M |
| 100% |
| Filing → |
| HUMA | SELL | 2024-11-20 | $13.2M | — | Filing → |
| HUMA | SELL | 2024-09-11 | $4.7M | — | Filing → |
| HUMA | BUY | 2024-09-03 | $8K | — | Filing → |